Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3).

Ezekowitz JA, Welsh RC, Gubbels C, Brass N, Chan M, Keeble W, Khadour F, Koshy TL, Knapp D, Sharma S, Sookram S, Tymchak W, Weiss D, Westerhout CM, Armstrong PW.

Can J Cardiol. 2014 Oct;30(10):1208-15. doi: 10.1016/j.cjca.2014.04.012. Epub 2014 Apr 18.

PMID:
25129333
2.

N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.

Rutten JH, Steyerberg EW, Boomsma F, van Saase JL, Deckers JW, Hoogsteden HC, Lindemans J, van den Meiracker AH.

Am Heart J. 2008 Jul;156(1):71-7. doi: 10.1016/j.ahj.2008.02.021. Epub 2008 May 27.

PMID:
18585499
3.

Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT-4).

Ezekowitz JA, Welsh RC, Weiss D, Chan M, Keeble W, Khadour F, Sharma S, Tymchak W, Sookram S, Brass N, Knapp D, Koshy TL, Zheng Y, Armstrong PW.

J Am Heart Assoc. 2015 Dec 1;4(12). pii: e002859. doi: 10.1161/JAHA.115.002859.

4.

Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide.

Gibler WB, Blomkalns AL, Collins SP.

Rev Cardiovasc Med. 2003;4 Suppl 4:S47-55. Review.

PMID:
14564228
5.

N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk.

van der Zee PM, Cornel JH, Bholasingh R, Fischer JC, van Straalen JP, De Winter RJ.

Am J Med. 2011 Oct;124(10):961-9. doi: 10.1016/j.amjmed.2011.05.026.

PMID:
21962317
6.

Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting.

Lam LL, Cameron PA, Schneider HG, Abramson MJ, Müller C, Krum H.

Ann Intern Med. 2010 Dec 7;153(11):728-35. doi: 10.7326/0003-4819-153-11-201012070-00006.

PMID:
21135296
7.

Risk stratification for suspected acute coronary syndromes and heart failure in the emergency department.

Peacock WF, Soto-Ruiz KM.

Acute Card Care. 2009;11(3):138-45. doi: 10.1080/17482940902989068.

PMID:
19452341
8.

The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE.

Takakuwa KM, Ou FS, Peterson ED, Pollack CV Jr, Peacock WF, Hoekstra JW, Ohman EM, Gibler WB, Blomkalns AL, Roe MT.

Clin Cardiol. 2009 Sep;32(9):498-505. doi: 10.1002/clc.20626.

9.

B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial.

Schneider HG, Lam L, Lokuge A, Krum H, Naughton MT, De Villiers Smit P, Bystrzycki A, Eccleston D, Federman J, Flannery G, Cameron P.

Ann Intern Med. 2009 Mar 17;150(6):365-71.

PMID:
19293069
10.

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.

Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R; Rapid Emergency Department Heart Failure Outpatient Trial investigators.

J Am Coll Cardiol. 2004 Sep 15;44(6):1328-33.

11.

Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure.

Lewandrowski K.

Clin Lab Med. 2009 Sep;29(3):561-71. doi: 10.1016/j.cll.2009.06.007.

PMID:
19840688
12.

The benefits of a rapid, point-of-care "TnI-Only" zero and 2-hour protocol for the evaluation of chest pain patients in the Emergency Department.

Blick KE.

Clin Lab Med. 2014 Mar;34(1):75-85, vi. doi: 10.1016/j.cll.2013.11.002. Epub 2014 Jan 14. Review.

PMID:
24507788
13.
14.

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP.

N Engl J Med. 2004 Feb 12;350(7):647-54.

15.

Short-term mortality risk in emergency department acute heart failure.

Peacock WF, Nowak R, Christenson R, DiSomma S, Neath SX, Hartmann O, Mueller C, Ponikowski P, Möckel M, Hogan C, Wu AH, Richards M, Filippatos GS, Anand I, Ng LL, Daniels LB, Morgenthaler N, Anker SD, Maisel AS.

Acad Emerg Med. 2011 Sep;18(9):947-58. doi: 10.1111/j.1553-2712.2011.01150.x.

16.

[Emergency department point of care testing: what are the benefits and for which patients?].

Ramlawi M, Delémont C.

Rev Med Suisse. 2011 Aug 24;7(305):1584-7. French.

PMID:
21922724
18.

A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial.

Than M, Aldous S, Lord SJ, Goodacre S, Frampton CM, Troughton R, George P, Florkowski CM, Ardagh M, Smyth D, Jardine DL, Peacock WF, Young J, Hamilton G, Deely JM, Cullen L, Richards AM.

JAMA Intern Med. 2014 Jan;174(1):51-8. doi: 10.1001/jamainternmed.2013.11362.

PMID:
24100783
19.

The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea.

Singer AJ, Thode HC Jr, Green GB, Birkhahn R, Shapiro NI, Cairns C, Baumann BM, Aghababian R, Char D, Hollander JE.

Acad Emerg Med. 2009 Jun;16(6):488-94. doi: 10.1111/j.1553-2712.2009.00415.x. Epub 2009 Apr 23.

20.

Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure.

Golcuk Y, Golcuk B, Velibey Y, Oray D, Atilla OD, Colak A, Kurtulmus Y, Yildirim A, Eren M.

Am J Emerg Med. 2013 Aug;31(8):1191-5. doi: 10.1016/j.ajem.2013.04.038. Epub 2013 Jun 4.

PMID:
23759684

Supplemental Content

Support Center